Literature DB >> 29450480

The Yet Unrealized Promise of Ovarian Cancer Screening.

Charles W Drescher1, Garnet L Anderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29450480     DOI： 10.1001/jamaoncol.2018.0028

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  3 in total

1.  Ultra-Sensitive TP53 Sequencing for Cancer Detection Reveals Progressive Clonal Selection in Normal Tissue over a Century of Human Lifespan.

Authors:  Jesse J Salk; Kaitlyn Loubet-Senear; Elisabeth Maritschnegg; Charles C Valentine; Lindsey N Williams; Jacob E Higgins; Reinhard Horvat; Adriaan Vanderstichele; Daniela Nachmanson; Kathryn T Baker; Mary J Emond; Emily Loter; Maria Tretiakova; Thierry Soussi; Lawrence A Loeb; Robert Zeillinger; Paul Speiser; Rosa Ana Risques
Journal:  Cell Rep       Date:  2019-07-02       Impact factor: 9.423

2.  The Immunological Role of CDK4/6 and Potential Mechanism Exploration in Ovarian Cancer.

Authors:  Chen Liu; Yuhan Huang; Yaoyuan Cui; Jun Zhou; Xu Qin; Li Zhang; Xi Li; Yuan Li; Ensong Guo; Bin Yang; Xi Li; Junpeng Fan; Xiong Li; Yu Fu; Si Liu; Dianxing Hu; Rourou Xiao; Zizhuo Wang; Yingyu Dou; Wei Wang; Wenting Li; Xiaohang Yang; Jingbo Liu; Wenju Peng; Tianyu Qin; Lixin You; Funian Lu; Chaoyang Sun
Journal:  Front Immunol       Date:  2022-01-14       Impact factor: 7.561

3.  The prevalence of occult ovarian cancer in the series of 155 consequently operated high risk asymptomatic patients - Slovenian population based study.

Authors:  Andreja Gornjec; Sebastijan Merlo; Srdjan Novakovic; Vida Stegel; Barbara Gazic; Andraz Perhavec; Ana Blatnik; Mateja Krajc
Journal:  Radiol Oncol       Date:  2020-05-28       Impact factor: 2.991
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.